Pharmacist-Led Deprescribing Halves Inappropriate Medications in Older Cancer Patients
This systematic review quantifies how pharmacist-driven deprescribing reduces potentially inappropriate medication exposure in older adults with cancer, while exposing a near-total absence of patient-centred outcome data.
Deprescribing cuts inappropriate medication use in cancer care for older adults.
Deprescribing potentially inappropriate medications (PIMs) in older adults with cancer can reduce morbidity and mortality, but its effectiveness remains unclear. The review found that deprescribing interventions reduced PIM use with a pooled relative risk (RR) of 0.49 in a meta-analysis of three studies. Deprescribing in geriatric oncology is feasible and reduces PIM exposure, but more robust studies are needed to validate broader patient-centered outcomes. Deprescribing reduces PIMs in older adults with cancer but evidence gaps persist.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Maleki S, Foo J, Zamani M, Mejia A, Soo WK, Turner JP, Kirkpatrick C
Citation:Maleki S, Foo J, Zamani M, et al. Deprescribing interventions in older adults with cancer: A systematic review and meta-analysis. Journal of geriatric oncology. 2026;18(1):104120. doi:10.1016/j.jgo.2026.104120